Monoclonal Antibody Therapy in Treating Patients With Advanced Colorectal Cancer

Summary

RATIONALE: Monoclonal antibodies can locate tumor cells and either kill them or deliver tumor-killing substances to them without harming normal cells. PURPOSE: Phase I/II trial to study the effectiveness of monoclonal antibody therapy in treating patients who have advanced colorectal cancer that has not responded to irinotecan.

Timeline

Start

2001-06

Primary completion

2004-11

Completion

2004-11

Drugs

Indications